Tower View Investment Management & Research LLC Sio Gene Therapies Inc. Transaction History

Tower View Investment Management & Research LLC

$165 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.28 - $0.44 $1,793 - $2,818	-6,406 Reduced 55.01%	5,239 $869,000
Q3 2022 Nov 15, 2022	SELL	$0.28 - $0.41 $2 - $3	-8 Reduced 0.07%	11,645 $1.35 Million
Q2 2022 Aug 08, 2022	BUY	$0.25 - $0.73 $2,913 - $8,506	11,653 New	11,653 $1.09 Million

Others Institutions Holding SIOX

# of Institutions

Shares Held

147K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

147K
Shares

$0
0.06% of portfolio
Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Sio Gene Therapies Inc.

Ticker SIOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,975,200
Description
Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical S...

More about SIOX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower View Investment Management & Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tower View Investment Management & Research LLC with notifications on news.

Account